Hyperuricemia as an outcome predictor in patients with ST-segment elevation myocardial infarction: Too good to be true?
Journal
Acta Cardiologica Sinica
Journal Volume
31
Journal Issue
1
Pages
87-88
Date Issued
2015
Author(s)
Abstract
Hyperuriacemia has been reported as an independent predictor of short- and long-term prognosis in patients with acute coronary syndrome.1,2 In the recent issue of Acta Cardiologica Sinica, Akgul et al. advocated that uric acid > 5.7 mg/dl was associated with increased in-hospital and six-month cardiovascular death in Turkish patients with ST-segment elevation myocardial infarction (STEMI) undergoing angioplasty.3 The level of uric acid upon hospital admission is a powerful predictor of six-month mortality, with a hazard ratio as high as 5.57. However, one aspect of the study must be noted. Although the enrollment of consecutive patients was stated, most patients in the study were at Killip’s class I (91.9%), which is not a common condition of general practice.
SDGs
Type
letter